Detecting Minimal Residual Diseases (MRD) and Monitoring Clonal Evolution Using Ultrasensitive Chromosomal Aberrations Detection (UCAD) in Multiple Myeloma
Clinical trial NCT06302699 · UNKNOWN
Trial details
- NCT number
- NCT06302699
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-05-01
- Primary completion
- 2024-05-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.